Haemonetics Corp Sample Contracts

WITNESSETH
Haemonetics Corp • June 22nd, 1998 • Surgical & medical instruments & apparatus • Illinois
AutoNDA by SimpleDocs
INDEMNIFICATION AGREEMENT
Indemnification Agreement • November 6th, 2018 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This Indemnification Agreement (“Agreement”) is made as of ________, by and between Haemonetics Corporation, a Massachusetts corporation (the “Company”), and ____________ (“Indemnitee”).

EXHIBIT 4 SHAREHOLDER RIGHTS AGREEMENT
Shareholder Rights Agreement • April 17th, 1998 • Haemonetics Corp • Surgical & medical instruments & apparatus • Delaware
WITNESSETH:
Haemonetics Corp • May 7th, 2002 • Surgical & medical instruments & apparatus • Massachusetts
ARTICLE I AMENDMENT TO CREDIT AGREEMENT -----------------------------
Revolving Credit Agreement • August 12th, 1999 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts
Haemonetics Corporation and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of March 5, 2021 0.00% Convertible Senior Notes due 2026
Indenture • March 5th, 2021 • Haemonetics Corp • Surgical & medical instruments & apparatus • New York

INDENTURE, dated as of March 5, 2021 between Haemonetics Corporation, a Massachusetts corporation, as issuer (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).

Page ARTICLE I Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Classification of Loans and Borrowings 26 SECTION 1.03. Terms Generally 26 SECTION 1.04. Accounting Terms; GAAP 26 SECTION 1.05. Interest Rates 27 ARTICLE II The Credits 27...
Credit Agreement • June 18th, 2018 • Haemonetics Corp • Surgical & medical instruments & apparatus • New York

CREDIT AGREEMENT (this “Agreement”) dated as of June 15, 2018, among HAEMONETICS CORPORATION, a Massachusetts corporation, the LENDERS from time to time party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent.

To: Haemonetics Corporation 125 Summer Street Boston, Massachusetts 02110 Attention: Telephone No.: Email:
Letter Agreement • March 16th, 2021 • Haemonetics Corp • Surgical & medical instruments & apparatus

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [____] (“Dealer”) and Haemonetics Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.

AND
Haemonetics Corp • February 6th, 1997 • Surgical & medical instruments & apparatus
AMENDMENT NO. 1 Dated as of March 1, 2021 to CREDIT AGREEMENT Dated as of June 15, 2018
Credit Agreement • March 1st, 2021 • Haemonetics Corp • Surgical & medical instruments & apparatus • Delaware

CREDIT AGREEMENT (this “Agreement”) dated as of June 15, 2018, among HAEMONETICS CORPORATION, a Massachusetts corporation, the LENDERS from time to time party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent.

AutoNDA by SimpleDocs
ARRANGEMENT AGREEMENTOctober 10, 2023
Arrangement Agreement • October 12th, 2023 • Haemonetics Corp • Surgical & medical instruments & apparatus

WHEREAS the Purchaser, through its wholly owned subsidiary AcquireCo, proposes to acquire all of the issued and outstanding Shares of the Corporation by way of an Arrangement, in accordance with the Plan of Arrangement, under the provisions of Sections 414-420 of the QBCA;

HAEMONETICS CORPORATION RESTRICTED STOCK UNIT AWARD AGREEMENT
Restricted Stock Unit Award Agreement • August 8th, 2023 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Award Agreement”), dated as of [●] (the “Date of Grant”), is delivered by Haemonetics Corporation (the “Company”) to [●] (the “Participant”).

THIRD AMENDMENT TO LEASE BETWEEN NEW AVON LIMITED PARTNERSHIP AND HAEMONETICS CORPORATION
Haemonetics Corp • June 10th, 2004 • Surgical & medical instruments & apparatus
HAEMONETICS CORPORATION PERFORMANCE SHARE UNIT AGREEMENT WITH «Name»
Performance Share Unit Agreement • May 22nd, 2019 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

THIS PERFORMANCE SHARE UNIT AGREEMENT (“Agreement”), dated as of «PSU Grant Date» (“Grant Date”) by and between Haemonetics Corporation, a Massachusetts corporation (“Company”), and «Name» (“Employee”), is entered into as follows:

INDEMNIFICATION AGREEMENT
Indemnification Agreement • November 3rd, 2011 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This Indemnification Agreement (“Agreement”) is made as of ________, 2011 by and between Haemonetics Corporation, a Massachusetts corporation (the “Company”), and ____________ (“Indemnitee”).

EXECUTIVE SEVERANCE AGREEMENT
Executive Severance Agreement • May 10th, 2016 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This Executive Severance Agreement (this “Agreement”) between Haemonetics Corporation, a Massachusetts corporation with its principal offices at 400 Wood Road, Braintree, Massachusetts, 02184, (herein referred to as the “Company”) and Christopher A. Simon (the “Officer”) is made effective as of the Start Date (as defined in the Employment Agreement, effective as of May 16, 2016, between the Officer and the Company (the “Employment Agreement”)). The Company and the Officer are collectively referred to herein as the “Parties” and individually referred to as a “Party.”

TENDER AND SUPPORT AGREEMENT
Tender and Support Agreement • February 19th, 2010 • Haemonetics Corp • Surgical & medical instruments & apparatus • Colorado

THIS TENDER AND SUPPORT AGREEMENT (this “Agreement”) dated as of January 31, 2010 is made by and among Haemonetics Corporation, a Massachusetts corporation (“Parent”), Atlas Acquisition Corp., a Colorado corporation and wholly owned subsidiary of Parent (“Purchaser”), and the securityholder of Global Med Technologies, Inc., a Colorado corporation (the “Company”) listed on Annex I (the “Stockholder”).

June 14, 2022 Michelle Basil c/o Haemonetics Corporation Boston, MA 02110 RE: Executive Vice President and General Counsel Retention and Transition Agreement Dear Michelle:
Retention and Transition Agreement • August 10th, 2022 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This Retention and Transition Agreement (this “Agreement”) sets forth the understanding between you and Haemonetics Corporation (the “Company”) regarding your continued employment as Executive Vice President and General Counsel of the Company and your planned resignation from the Company and transition. On behalf of the Board of Directors of the Company, I want to thank you for your willingness to provide continued service as Executive Vice President and General Counsel in order to ensure a seamless and successful transition to the next Executive Vice President and General Counsel of the Company.

CHANGE IN CONTROL AGREEMENT
Change in Control Agreement • November 7th, 2017 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This Change in Control Agreement (this “Agreement”) is made effective on Insert Date (the “Effective Date”) between Haemonetics Corporation, a Massachusetts corporation with its principal offices at 400 Wood Road, Braintree, Massachusetts, 02184 (herein referred to as the “Company”), and Name (the “Executive”). The Company and the Executive are collectively referred to herein as the “Parties” and individually referred to as a “Party.”

CHANGE IN CONTROL AGREEMENT
Change in Control Agreement • May 10th, 2016 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

This Change in Control Agreement (this “Agreement”) between Haemonetics Corporation, a Massachusetts corporation with its principal offices at 400 Wood Road, Braintree, Massachusetts, 02184, (herein referred to as the “Company”) and Christopher A. Simon (the “Officer”), is made effective as of the Start Date (as defined in the Employment Agreement, effective as of May 16, 2016, between the Officer and the Company (the “Employment Agreement”)) (the “Effective Date”). The Company and the Officer are collectively referred to herein as the “Parties” and individually referred to as a “Party.”

Contract
Office Lease Agreement • February 8th, 2024 • Haemonetics Corp • Surgical & medical instruments & apparatus

CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL, IS THE TYPE THAT HAEMONETICS CORPORATION TREATS AS CONFIDENTIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED [***].

HAEMONETICS CORPORATION PERFORMANCE SHARE UNIT AGREEMENT WITH
Performance Share Unit Agreement • November 7th, 2017 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts

THIS PERFORMANCE SHARE UNIT AGREEMENT (“Agreement”), dated as of ___________ , 2017 (“Grant Date”) by and between Haemonetics Corporation, a Massachusetts Corporation (“Company”), and [insert: applicable name] (“Employee”), is entered into as follows:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!